Hingham Institution (NASDAQ:HIFS) reported quarterly earnings of $6.93 per share. This is a 10.53 percent increase over earnings of $6.27 per share from the same period last year.
Regeneron Awarded $326M Government Contract For COVID-19 Antibody Therapy Development
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was awarded a government contract valued at up to $326 million on Tuesday.